FERMENTA

Fermenta Biotech Limited

Fermenta Biotech Limited (FERMENTA) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

fermentabiotech.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹486.00
Market cap
1,430 Cr
Stock P/E
19.8 · FY26
P/B
3.48
Dividend yield
0.5%
ROE (FY26)
17.5%
ROCE (FY26)
21.1%
Operating margin (FY26)
14.9%
Debt / equity (FY26)
0.27
OCF / EBITDA (FY26)
93.0%
OCF / EBITDA (3Y)
100.6%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Fermenta Biotech makes vitamin D3 and related nutrition ingredients that go into dietary supplements, pharmaceuticals, fortified foods and animal feed, and sells to brands in more than 60 countries.

Company snapshot

85thBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓101% of operating profit came in as cash over the last three years — profits are backed by real cash.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Sales99 Cr96 Cr105 Cr97 Cr140 Cr122 Cr122 Cr
Operating expenses (approx.)89 Cr78 Cr86 Cr91 Cr103 Cr102 Cr104 Cr
EBITDA10 Cr18 Cr20 Cr6 Cr37 Cr20 Cr18 Cr
OPM %10.2%18.5%18.6%6.1%26.4%16.5%14.8%
Other income5 Cr3 Cr1 Cr5 Cr4 Cr5 Cr4 Cr
Interest5 Cr4 Cr6 Cr3 Cr3 Cr3 Cr3 Cr
Depreciation6 Cr6 Cr6 Cr6 Cr6 Cr5 Cr5 Cr
Profit before tax3 Cr10 Cr-0.89 Cr0.91 Cr32 Cr26 Cr15 Cr
Tax %-29.8%20.6%-450.8%886.0%-4.2%29.0%35.1%
Net profit4 Cr8 Cr-5 Cr-7 Cr33 Cr19 Cr10 Cr
EPS (₹)₹2.56₹2.66₹-1.30₹-2.41₹11.79₹6.66₹3.40

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales166 Cr303 Cr405 Cr293 Cr377 Cr399 Cr350 Cr336 Cr469 Cr525 CrSign in free for the trailing twelve months
Operating expenses (approx.)154 Cr210 Cr256 Cr228 Cr296 Cr337 Cr332 Cr308 Cr360 Cr426 CrSign in free for the trailing twelve months
EBITDA12 Cr93 Cr149 Cr65 Cr82 Cr61 Cr18 Cr28 Cr110 Cr100 CrSign in free for the trailing twelve months
OPM %7.2%30.7%36.8%22.3%21.6%15.4%5.1%8.4%23.4%19.0%Sign in free for the trailing twelve months
Other income3 Cr9 Cr12 Cr12 Cr8 Cr8 Cr8 Cr11 Cr12 Cr22 CrSign in free for the trailing twelve months
Interest10 Cr14 Cr21 Cr19 Cr18 Cr17 Cr21 Cr17 Cr14 Cr12 CrSign in free for the trailing twelve months
Depreciation10 Cr12 Cr12 Cr15 Cr20 Cr26 Cr28 Cr25 Cr24 Cr22 CrSign in free for the trailing twelve months
Profit before tax-6 Cr69 Cr128 Cr43 Cr52 Cr27 Cr-52 Cr-10 Cr83 Cr96 CrSign in free for the trailing twelve months
Tax %-45.6%30.4%8.4%-37.1%17.6%44.1%-3.2%-143.2%8.2%26.7%Sign in free for the trailing twelve months
Net profit-9 Cr48 Cr117 Cr60 Cr43 Cr15 Cr-54 Cr-24 Cr76 Cr70 CrSign in free for the trailing twelve months
EPS (₹)₹-49.82₹155.63₹120.31₹20.63₹15.77₹5.35₹-17.85₹-7.99₹26.35₹24.70Sign in free for the trailing twelve months
Dividend payout %————0.0%47.9%——4.7%10.4%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital2 Cr2 Cr5 Cr14 Cr14 Cr14 Cr14 Cr14 Cr15 Cr14 Cr
Reserves142 Cr124 Cr228 Cr295 Cr346 Cr358 Cr300 Cr274 Cr344 Cr392 Cr
Borrowings77 Cr165 Cr195 Cr206 Cr207 Cr236 Cr217 Cr132 Cr109 Cr109 Cr
Other liabilities58 Cr84 Cr109 Cr98 Cr120 Cr99 Cr107 Cr130 Cr147 Cr139 Cr
Total liabilities308 Cr387 Cr555 Cr614 Cr687 Cr707 Cr636 Cr548 Cr614 Cr648 Cr
Fixed assets (net)84 Cr91 Cr97 Cr104 Cr154 Cr207 Cr205 Cr236 Cr210 Cr206 Cr
CWIP4 Cr3 Cr21 Cr67 Cr53 Cr30 Cr42 Cr2 Cr16 Cr13 Cr
Investments9 Cr3 Cr2 Cr0.26 Cr69 Cr68 Cr32 Cr6 Cr4 Cr4 Cr
Loans & advances————5 Cr0.01 Cr1 Cr5 Cr1 Cr0.07 Cr
Inventories39 Cr51 Cr88 Cr129 Cr162 Cr159 Cr130 Cr87 Cr124 Cr153 Cr
Trade receivables45 Cr69 Cr66 Cr70 Cr68 Cr87 Cr42 Cr70 Cr95 Cr112 Cr
Cash & bank2 Cr32 Cr41 Cr8 Cr17 Cr13 Cr35 Cr22 Cr28 Cr32 Cr
Other assets125 Cr138 Cr241 Cr236 Cr160 Cr142 Cr149 Cr120 Cr137 Cr130 Cr
Total assets308 Cr387 Cr555 Cr614 Cr687 Cr707 Cr636 Cr548 Cr614 Cr648 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity2 Cr59 Cr90 Cr34 Cr63 Cr43 Cr117 Cr105 Cr41 Cr93 Cr
Cash from investing7 Cr-101 Cr-97 Cr-44 Cr-42 Cr-26 Cr-56 Cr-15 Cr-0.16 Cr-43 Cr
Cash from financing-12 Cr89 Cr12 Cr-47 Cr-1 Cr-22 Cr-41 Cr-91 Cr-51 Cr-42 Cr
Net cash flow-4 Cr47 Cr6 Cr-57 Cr20 Cr-4 Cr20 Cr-1 Cr-10 Cr8 Cr
Free cash flow (OCF − Capex)-17 Cr40 Cr55 Cr-34 Cr7 Cr6 Cr76 Cr86 Cr19 Cr62 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %1.6%27.5%33.4%12.1%12.3%7.2%-5.9%1.7%20.8%21.1%
ROE %-6.6%26.0%44.0%19.2%11.8%4.1%-17.2%-8.4%21.3%17.5%
Debtor days98835987668043767477
Inventory days173219309444416439423414379373
Days payable122172151195159178149308237189
Cash conversion cycle149130217337322341317182215262
OCF / EBITDA %16.0%63.7%60.7%52.8%76.7%70.7%650.5%374.7%37.3%93.0%
OCF / EBITDA % (3 years)——59.7%59.9%63.4%67.4%138.3%246.9%168.7%100.6%
Debt / equity0.541.310.840.670.570.640.700.460.310.27
Current ratio1.211.761.901.461.481.521.211.401.581.87
Net debt / EBITDA6.291.431.043.042.333.6310.123.930.740.77